Where Do Analysts See These Stocks Going: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), Zimmer Biomet Holdings Inc (NYSE:ZBH)

June 27, 2017

According to data provided by Zacks Research, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a consensus target price of $462.705 on the stock. Out of the polled analysts providing targets, the high is currently $598, while the low is resting at $327. Analyst price targets may vary depending on the individual method used to calculate the estimate.
Turning to earnings, analysts are expecting Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to post a current quarter EPS of $2.67. This consensus number is compiled by Zacks Research. For the period ending on 2017-03-31, the company reported EPS for the quarter of $2.16. The resulting surprise factor from the difference between the reported number and the consensus estimate going into earnings was -13.6%. After a company reports earnings, the stock may see increased activity. The next earnings report date is scheduled on or near 2017-08-03.
In terms of analyst ratings, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a current ABR of 2.16. This average broker recommendation is given by Zacks using a scale from 1 to 5. According to this scale, a rating of 1 or 2 would indicate a Buy, and a rating of 4 or 5 would signify a Sell recommendation. A 3 would indicate a Hold on the stock.

Zimmer Biomet Holdings Inc (NYSE:ZBH) shares are trading -0.07% thus far today and have traded in the range of 128.59 – 129.11 during the current session. In order to take a look at where the stock might headed longer term, we can also look at different sets of data. Sell-side research firms currently have a consensus one year price target of $132.05 on the stock according to First Call. This number can often vary from the Zacks or FactSet mean targets. The sell-side analysts are projecting earnings per share of $1.96 for the next fiscal quarter. For the current year, analysts are predicting earnings of $8.54 per share according to First Call.

Stock Technicals in Focus

In looking at where the stock is trading on a technical level, the stock is trading +6.27% away from its 50 day moving average of $121.37. Based on the most recent available data, the equity is -3.18% off of its 52-week high of $133.21 and +34.86% away from its 52-week low which is $95.63. In taking a look at the company’s valuation, the firm’s price to earnings ratio stands at 52.79. This is a crucial indicator investors watch as higher ratios compared to peers, would suggest higher future earnings growth potential for the stock. The price to current year EPS estimates from research analysts currently stands at 15.10. In looking further ahead, potential investors should note that the company’s price to next year’s EPS estimates is 13.91.

Today, the stock opened at $128.82 and the last bid at the time of writing stood at $128.97. During the session thus far, the equity dipped down to $128.59 and touched $129.11 as the high point. Zimmer Biomet Holdings, Inc. has a market cap of 26.01B and has seen an average daily volume of 1209770 over the past three months.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

By DR Staff Writer

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with MarketBeat's FREE daily email newsletter:

Latest Stories